Why Shares of Intellia Therapeutics Are Jumping Today
Shares of Intellia Therapeutics (NASDAQ: NTLA) were up 12% at 3:45 p.m. EDT today after the company reported earnings and updated investors on its clinical trials.
Image source: Getty Images.
Wall Street was already jazzed over the success of NTLA-2001. That treatment became the first using clustered regularly interspersed short palindromic repeats (CRISPR) gene-editing technology to be successfully deployed directly in humans. Management's update added two more therapies to the list of first-in-human trials it plans this year. Those are its NTLA-2002 for hereditary angioedema, a disease that causes severe swelling, and NTLA-5001 for acute myeloid leukemia.
Source Fool.com
